In adults with psoriasis, adding methotrexate to adalimumab did not improve effectiveness or drug survival compared with ...

New psoriasis drug Zoryve approved. How to use & why Black American participation in clinical trials is vital for health ...

US claims data show patients with generalized pustular psoriasis (GPP) face up to a 4-fold higher mortality risk compared ...

Bimekizumab use for 4 years among patients with plaque psoriasis is associated with sustained efficacy outcomes and no new safety signals.

For patients with psoriasis receiving biologic therapy, residual inflammation (RI), defined as increased inflammatory markers in blood, characterized by high-sensitivity C-reactive protein, despite ...

A new study highlights a significant medical concern for individuals suffering from psoriasis, revealing that even when skin ...

May 27, 2025 — Researchers have found that central body fat, especially around the abdomen, is more strongly linked to psoriasis risk than total body fat, particularly in women. This link ...

Discover a study in which researchers examined three international cohorts of patients with moderate-to-severe psoriasis ...

Mumbai: Sun Pharmaceutical Industries Limited has announced the discontinuation of two clinical trials evaluating SCD-044, a ...

Sun Pharma’s experimental drug SCD-044 did not meet its main goals in Phase 2 trials for psoriasis and atopic dermatitis. The ...